HomePTX • ASX
add
Prescient Therapeutics Ltd
Previous close
$0.049
Day range
$0.049 - $0.050
Year range
$0.037 - $0.063
Market cap
51.52M AUD
Avg Volume
907.41K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Nasdaq
8 hours ago
PT Alamtri Resources Indonesia Tbk (PADEF) Price Target Decreased by 12.68% to 0.16
4.80%
18.69%
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.55M | 75.34% |
Operating expense | 4.02M | 61.47% |
Net income | -2.44M | -5.52% |
Net profit margin | -156.80 | 39.82% |
Earnings per share | — | — |
EBITDA | -2.46M | -53.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.93M | -52.27% |
Total assets | 14.56M | -28.59% |
Total liabilities | 3.17M | 36.50% |
Total equity | 11.39M | — |
Shares outstanding | 805.32M | — |
Price to book | 4.90 | — |
Return on assets | -42.27% | — |
Return on capital | -54.05% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.44M | -5.52% |
Cash from operations | -727.11K | 62.84% |
Cash from investing | 1.00M | -75.00% |
Cash from financing | -17.14K | — |
Net change in cash | 260.74K | -87.20% |
Free cash flow | -1.38M | -43.48% |
About
Prescient Therapeutics Ltd is a clinical stage oncology company. The company is focused on the development of a universal CAR-T platform, enhanced CAR-T cell manufacturing & function and on two small molecule drug targeted therapies. Wikipedia
Founded
May 22, 1986
Website
Employees
3
